FDA Issues a Warning Letter to EPH Technologies
Today, the U.S. Food and Drug Administration issued a warning letter to EPH Technologies, Inc. of New Mexico for marketing and selling unapproved and misbranded drugs, including Detoxoplex as a treatment f...
November 27, 2019
8:23 am By Neha Mule